Asia PR News

PHILADELPHIA and LONDON, Oct. 31 /PRNewswire-AsiaNet/ –

More than 25 Years of Archived Biomedical and Pharmacological Records
Accessible in Electronic Format for the First Time

Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC)
and leading provider of information solutions to the worldwide research and
business communities, today announced that it has added EMBASE(R) Classic to
the Dialog(R) (File 772) and DataStar(R) (EM73, EMXX) platforms, providing
access to more than 25 years of archived life sciences data available for the
first time in electronic format. For more information about the EMBASE Classic
database on Dialog and DataStar, visit www.dialog.com/embaseclassic.

EMBASE Classic, produced by Elsevier, includes the bibliographic records
originally published in the 43 Excerpta Medica abstract print journals from
1947 through 1973. The fully digitized database is drawn from approximately
3,400 international journal titles, with a focus on European and North
American published literature including non-English language articles. EMBASE
Classic contains more than 1.8 million records from the biomedical and
pharmacological literature. The historical data in EMBASE Classic, combined
with up-to-date records in the EMBASE database (File 73/EMZZ), gives
researchers approximately 60 years of information regarding medical and drug-
related subjects.

"With EMBASE Classic, researchers can now review advancements made during
an extremely fertile period for the sciences, particularly in the areas of
molecular biology, marine sciences, vaccines and other drug therapies," said
Geoffrey Dick, Director of Publisher Management, Thomson Scientific. "The
archived literature should prove invaluable in reviews of toxicology, adverse
events and prior art for patent prosecution."

EMBASE Classic enhances research in:

— Drug development
— Pipeline intelligence
— Designing and mounting clinical investigations
— New uses for old drugs
— Approved uses for drugs
— Adverse events and reactions monitoring on old drugs or endogenous
compounds
— Preparation of new drug applications
— Product safety and compliance monitoring

EMBASE Classic significantly expands the collection of biomedical and
pharmacological literature sought by research professionals. The new database
complements current Dialog and DataStar life sciences offerings, including
EMBASE(R) (1974+ in File 73/EMZZ), as well as the recently added BIOSIS
Previews(R) (File 5/BIOL), Zoological Record Online(R) and MEDLINE (1951+ in
File 155/MEZZ) archive data.

About The Thomson Corporation
The Thomson Corporation (www.thomson.com) is a global leader in providing
essential electronic workflow solutions to business and professional
customers. With operational headquarters in Stamford, Conn., Thomson provides
value-added information, software tools and applications to professionals in
the fields of law, tax, accounting, financial services, scientific research
and healthcare. The Corporation’s common shares are listed on the New York
and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation. Its
information solutions assist professionals at every stage of research and
development-from discovery to analysis to product development and
distribution. Thomson Scientific information solutions can be found at
scientific.thomson.com.

SOURCE Thomson Scientific

CONTACT: Kevin Bonsor of Thomson Scientific,
+1-919-461-7428,
kevin.bonsor@thomson.com

Web site: http://www.scientific.thomson.com
http://www.dialog.com/embaseclassic
(TOC TOC.)